Vectibix (panitumumab)

pCPA File Number: 22844

Negotiation Status:

Active Negotiation

Indication(s):

Metastatic Colorectal Cancer (mCRC) patients with left-sided primary tumours that express wild-type RAS (In combination with chemotherapy)

Sponsor/Manufacturer:

Amgen Canada Inc.

CDA-AMC Project Number:

PX0333-000

pCPA Engagement Letter Issued:

2024-07-22

Negotiation Process Concluded:

Not Applicable